JP2023519824A5 - - Google Patents

Info

Publication number
JP2023519824A5
JP2023519824A5 JP2022556491A JP2022556491A JP2023519824A5 JP 2023519824 A5 JP2023519824 A5 JP 2023519824A5 JP 2022556491 A JP2022556491 A JP 2022556491A JP 2022556491 A JP2022556491 A JP 2022556491A JP 2023519824 A5 JP2023519824 A5 JP 2023519824A5
Authority
JP
Japan
Prior art keywords
compound according
optionally substituted
alkyl
cycloalkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022556491A
Other languages
English (en)
Japanese (ja)
Other versions
JP7763772B2 (ja
JP2023519824A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025547 external-priority patent/WO2021202977A1/en
Publication of JP2023519824A publication Critical patent/JP2023519824A/ja
Publication of JP2023519824A5 publication Critical patent/JP2023519824A5/ja
Priority to JP2025177542A priority Critical patent/JP2026009184A/ja
Application granted granted Critical
Publication of JP7763772B2 publication Critical patent/JP7763772B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022556491A 2020-04-03 2021-04-02 補体阻害剤としてのピロロピリミジンアミン Active JP7763772B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025177542A JP2026009184A (ja) 2020-04-03 2025-10-22 補体阻害剤としてのピロロピリミジンアミン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063004799P 2020-04-03 2020-04-03
US63/004,799 2020-04-03
PCT/US2021/025547 WO2021202977A1 (en) 2020-04-03 2021-04-02 Pyrrolopyrimidine amines as complement inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025177542A Division JP2026009184A (ja) 2020-04-03 2025-10-22 補体阻害剤としてのピロロピリミジンアミン

Publications (3)

Publication Number Publication Date
JP2023519824A JP2023519824A (ja) 2023-05-15
JP2023519824A5 true JP2023519824A5 (https=) 2024-05-02
JP7763772B2 JP7763772B2 (ja) 2025-11-04

Family

ID=77929437

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022556491A Active JP7763772B2 (ja) 2020-04-03 2021-04-02 補体阻害剤としてのピロロピリミジンアミン
JP2025177542A Pending JP2026009184A (ja) 2020-04-03 2025-10-22 補体阻害剤としてのピロロピリミジンアミン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025177542A Pending JP2026009184A (ja) 2020-04-03 2025-10-22 補体阻害剤としてのピロロピリミジンアミン

Country Status (25)

Country Link
US (1) US20230159536A1 (https=)
EP (1) EP4125914A4 (https=)
JP (2) JP7763772B2 (https=)
KR (1) KR20220163955A (https=)
CN (1) CN115427044A (https=)
AR (1) AR121715A1 (https=)
AU (1) AU2021246098A1 (https=)
BR (1) BR112022018067A2 (https=)
CA (1) CA3176808A1 (https=)
CL (1) CL2022002649A1 (https=)
CO (1) CO2022015630A2 (https=)
CR (1) CR20220553A (https=)
CU (1) CU20220060A7 (https=)
DO (2) DOP2022000211A (https=)
EC (1) ECSP22085221A (https=)
GE (1) GEP20257841B (https=)
IL (1) IL296978A (https=)
JO (2) JOP20220227A1 (https=)
MX (1) MX2022012056A (https=)
PE (1) PE20230601A1 (https=)
PY (1) PY2126225A (https=)
TN (1) TN2022000255A1 (https=)
TW (1) TWI912303B (https=)
UY (1) UY39150A (https=)
WO (1) WO2021202977A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023069301A1 (en) * 2021-10-18 2023-04-27 Alexion Pharmaceuticals, Inc. Use of complement factor d inhibitor for treatment of lupus nephritis and immunoglobulin a nephropathy
WO2024008121A1 (zh) * 2022-07-06 2024-01-11 南京明德新药研发有限公司 二氟取代的氮杂双环化合物及其应用
JP2025530036A (ja) * 2022-09-01 2025-09-10 エフ. ホフマン-ラ ロシュ アーゲー ビカシナビンの投与レジメン
US11945818B1 (en) 2023-09-06 2024-04-02 King Faisal University Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors
US11964981B1 (en) 2023-09-18 2024-04-23 King Faisal University Substituted pyrimido[4,5-b]indoles as CK2 inhibitors
WO2025217212A1 (en) * 2024-04-09 2025-10-16 The Regents Of The University Of California Mac1 inhibitors and uses thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
LU86084A1 (fr) 1985-09-20 1987-04-02 Faco Sa Apparei de massage electrique
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
WO1990013332A1 (en) 1989-05-11 1990-11-15 Cedars-Sinai Medical Center Stent with sustained drug delivery
DE69110787T2 (de) 1990-02-28 1996-04-04 Medtronic, Inc., Minneapolis, Minn. Intraluminale prothese mit wirkstoffeluierung.
US5429634A (en) 1993-09-09 1995-07-04 Pdt Systems Biogenic implant for drug delivery and method
US5419760A (en) 1993-01-08 1995-05-30 Pdt Systems, Inc. Medicament dispensing stent for prevention of restenosis of a blood vessel
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
JPH11292840A (ja) * 1998-04-06 1999-10-26 Soyaku Gijutsu Kenkyusho:Kk ノルスタチン誘導体又はその塩
EP1144373B1 (en) 1999-01-13 2005-10-19 Genentech, Inc. Serine protease inhibitors
US6770729B2 (en) 2002-09-30 2004-08-03 Medtronic Minimed, Inc. Polymer compositions containing bioactive agents and methods for their use
PT2661433T (pt) 2011-01-04 2017-10-24 Novartis Ag Compostos de indole ou seus análogos úteis para o tratamento da degeneração macular relacionada com a idade (amd)
CN104379579B (zh) 2012-06-28 2017-03-08 诺华股份有限公司 吡咯烷衍生物及其作为补体途径调节剂的用途
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035348A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Alkyne compounds for treatment of medical disorders
AR105809A1 (es) * 2015-08-26 2017-11-08 Achillion Pharmaceuticals Inc Compuestos para el tratamiento de trastornos médicos
AR105808A1 (es) 2015-08-26 2017-11-08 Achillion Pharmaceuticals Inc Compuestos de amida para el tratamiento de trastornos médicos
US10385097B2 (en) 2015-08-26 2019-08-20 Achillion Pharmaceuticals, Inc. Ether compounds for treatment of medical disorders
TWI747873B (zh) 2016-02-01 2021-12-01 美商百歐克斯製藥公司 苯并吡唑化合物及其類似物
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
WO2018229543A2 (en) 2017-06-14 2018-12-20 Lifesci Pharmaceuticals, Inc. Therapeutic inhibitory compounds
TWI873092B (zh) 2018-04-06 2025-02-21 美商百歐克斯製藥公司 取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑

Similar Documents

Publication Publication Date Title
JP2023519824A5 (https=)
IL296978A (en) Pyrrolopyrimidines are reliable as complement inhibitors
JP2024521878A5 (https=)
JP2024541929A5 (https=)
JP2015515976A5 (https=)
KR100530297B1 (ko) 옥사졸리디논의 제조 방법
JP2961267B2 (ja) イミダゾール又はピラゾール誘導体
JP6633539B2 (ja) 2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−1−(5−置換−ピリジン−2−イル)−3−(1h−テトラゾール−1−イル)プロパン−2−オールおよびその調製工程
IL305879A (en) Benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors are converted
JP2017508733A5 (https=)
JP2018531218A5 (https=)
CA2860323A1 (en) Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
KR20010031859A (ko) 옥사졸리디논의 제조 방법
JP2018515581A5 (https=)
EP2797597A1 (en) Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
JP2023542949A5 (https=)
JP2018536648A5 (https=)
WO2016088082A1 (en) Amidomethyl-biaryl derivatives complement factor d inhibitors and uses thereof
JP2021522262A5 (https=)
AU2002360238B2 (en) Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
JP2025508272A5 (https=)
JP2021510692A5 (https=)
JPS60158192A (ja) 殺菌・殺カビ性イミダゾール及びトリアゾール
JPS62502046A (ja) セファロスポリン中間体の製法
JP5795581B2 (ja) 除草活性を有するヘテロアリール置換環状ジオンまたはその誘導体